About Immunologix
Immunologix is a company based in Charleston (United States) founded in 2008 was acquired by Precigen in October 2011. Immunologix has raised $1.54 million across 3 funding rounds from investors including Precigen and sclaunch. Immunologix operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.
- Headquarter Charleston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immunologix
Immunologix has successfully raised a total of $1.54M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $250.95 thousand completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immunologix
Immunologix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Precigen and sclaunch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
|
Locked | Locked | Locked |
Investor details for Immunologix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immunologix
Investment portfolio details for Immunologix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immunologix
Detailed financials for Immunologix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunologix Comparisons
Peer comparison for Immunologix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immunologix
Immunologix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Protein-based assays are developed for life science research.
|
|
| Locked | Locked | Locked |
A proteomics platform is developed for analyzing the human proteome.
|
|
| Locked | Locked | Locked |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| Locked | Locked | Locked |
Digital platform transforming the delivery of biologic medicines
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
Detailed competitors of Immunologix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunologix
Complete news archive for Immunologix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunologix
Immunologix was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Immunologix is headquartered in Charleston, United States. It is registered at Charleston, South Carolina, United States.
Immunologix is a funded company, having raised a total of $1.54M across 3 funding rounds to date.
Immunologix was founded in 2008 in Charleston, United States, within the biotechnology sector. Focus was placed on developing human monoclonal antibodies targeting viral, bacterial, tumor, and auto antigens. Operations centered on antibody-based therapeutics for various biological targets. The company was acquired by Intrexon in October 2011, concluding its independent activities.
Immunologix's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
Immunologix has 2 investors. Key investors include Precigen, and sclaunch.